Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Skinternal Medicine: An Update On Cutaneous Manifestations of Systemic Disease (Case 5)

Description

Frank Wang, an associate professor at the University of Michigan, presented a case involving an 82-year-old female with painful oral lesions and a groin rash, complicating her ongoing treatment for seronegative inflammatory arthritis. After a detailed examination, including photos showcasing the erosions of her lips and groin lesions, the discussion highlighted potential diagnoses such as immunobullous disorders and medication toxicity. Ultimately, the case revealed a methotrexate-induced toxicity, due to an inadvertent daily dosing of methotrexate instead of the prescribed weekly dosage. The patient also experienced a sinus infection and was prescribed amoxicillin, contributing to her symptoms. Laboratory tests noted low hemoglobin and elevated BUN, but methotrexate levels were undetectable. The initial treatment involved stopping methotrexate and administering IV leukovorin to manage the mucositis. Wang emphasized the seriousness of methotrexate toxicity, which can manifest as mucosal erosions similar to pemphigus vulgaris and can affect renal function. He outlined risk factors including older age, inadvertent daily dosing, and concurrent medications that may affect methotrexate metabolism. Recommendations concluded with the need for vigilance in monitoring patients on methotrexate, even at low doses, and the importance of recognizing symptoms of toxicity to ensure timely and appropriate management.

View more

Conclusions

  • An 82-year-old female developed mucositis and epidermal necrosis due to methotrexate toxicity.
  • The patient inadvertently took a daily dose of methotrexate, exacerbating her condition.
  • Methotrexate-induced toxicity can present with mucosal erosions and may mimic other conditions such as pemphigus vulgaris.
  • Risk factors for methotrexate toxicity include older age, renal impairment, drug interactions, and inadvertent dosing errors.
  • In addition to ceasing methotrexate, intravenous leukovorin is an effective initial treatment for toxicity.
  • Laboratory tests frequently show cytopenias and renal function abnormalities during methotrexate toxicity evaluation.
  • Undetectable serum methotrexate levels do not rule out the possibility of toxicity, emphasizing clinical judgment in diagnosis.
  • J Am Acad Dermatol 2017;77:247-55
  • Actas Dermosifiliogr 2020; 111(5):436-439
  • J Am Acad Dermatol 2015;73:484-90